Grades are up at the AMSA PharmFree Scorecard, which assessed the conflict of interest policies of all 150 medical schools in the U.S.   To develop the scorecard, the American Medical Student Association teamed up with RxP, which has been working to help schools strengthen their policies on limiting pharmaceutical marketing on campus.

Like your micro-econ class, it was pretty hard to get an A – only 7 schools did, along with 14 Bs, also a tough get, since the grades were tabulated on 11 areas of industry influence as diverse as gifts, purchasing and formulary, site access for industry vendors, and continuing medical education.

60 schools (40%) received a grade of F. This includes 15 that either submitted policies graded as F or indicated they had no relevant policies, as well as 16 schools that declined to submit policies and 29 that did not respond to repeated attempts at follow-up.

But unlike those pesky online grades posted after your professor was already well on his way to Provence with the kids, the AMSA interactive website allows you to sort by state, city, and strength of individual domain, plus read excerpts of actual policies that took interesting approaches and read model language for schools looking to raise their scores with some extra credit.

Plus, check out the pie chart and brush up on your geography with a spiffy map of the U.S.

And yes, all you primary junkies, Puerto Rico’s on there.